Zero calcium score does not equal zero coronary risk
High calcium scores are commonly considered a risk factor for coronary stenosis, but even a zero calcium score doesn’t assure coronary health in a high-risk population, concluded a pair of studies presented at ECR 2009.
High calcium scores are commonly considered a risk factor for coronary stenosis, but even a zero calcium score doesn’t assure coronary health in a high-risk population, concluded a pair of studies presented at ECR 2009.
Researchers from the Netherlands and China compared calcium scores against coronary stenosis in a high-risk population. In both studies, high calcium scores generally correlated with coronary stenosis.
In a small subset, however, zero calcium scores did not assure the absence of coronary stenosis.
A study from the University Medical Center Groningen in the Netherlands found that patients with a zero coronary score had a 93% chance of not having coronary stenosis but could not rule out stenosis when the pretest probability was high.
The study included 160 patients. Most (96) were admitted for chest pain. The remaining 64 were considered to have a high cardiovascular risk profile.
Among the study set, 43 had zero calcium scores. CT angiography scans found that three of the 43 (7%) had significant stenosis.
The study also showed that patients without stenosis on CTA had a mean calcium score of 109 (Agatston scale). Those with one or more signs of stenosis on CTA had a mean calcium score of 1030.
The distribution of calcium scores was the following:
• zero, 37%
• 10 to 100, 13%
• 101 to 400, 18%
• more than 400, 36%
A study from Tuen Mun Hospital in Hong Kong examined 147 patients admitted for chest pain. Sixty-eight had zero calcium scores. Among those, four (5.9%) had significant stenosis on CTA angiography. Another four had mild stenosis on CTA.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
